Sun Pharma adds â¹9,523 crore in market cap in one day
India's largest drugmaker Sun Pharmaceutical added â¹9,523 crore to market capitalisation on Friday after the US health regulator USFDA didn't recommend any action against the company's Halol plant in Gujarat. The company's shares surged about 8%, taking its total market valuation to â¹1.26 lakh crore. The drugmaker faced regulatory scrutiny over manufacturing standards violations at the plant. 